Skip to content

A prospective, multicenter, randomized, parallel, active-controlled, non-inferiority clinical study of disposable tubular retractor for brain surgery

A prospective, multicenter, randomized, parallel, active-controlled, non-inferiority clinical study of disposable tubular retractor for brain surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044829
Enrollment
Unknown
Registered
2021-03-29
Start date
2021-01-19
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain surgery such as hypertensive cerebral hemorrhage and brain tumors

Interventions

exprimental group:exprimental production
control group:control production

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years males or females; 2. Brain surgery patients with hypertensive cerebral hemorrhage, brain tumor and so on who are diagnosed by imaging examination (CT or MRI); 3. Patients or guardians agree to participate the trial and sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with late stage of cerebral hernia; 2. Patients with aneurysm or cerebral arteriovenous malformation; 3. Patients with cardiac arrest caused by craniocerebral trauma, or patients with bilateral mydriasis and unstable vital signs caused by severe craniocerebral trauma; 4. Patients with inflammation in the operation area; 5. Patients allergic to known materials (polycarbonate, acrylonitrile butadiene styrene copolymer, cycloolefin polymer and 304 stainless steel); 6. Lactating women and pregnant women; 7. Patient had participated in clinical studies of other drugs or devices within 3 months before signing the informed consent (excluding registered Studies); 8. Patient who is judged ineligible by the investigator.

Design outcomes

Primary

MeasureTime frame
Comprehensive score of clinical effect;

Secondary

MeasureTime frame
Performance evaluation of device;Incidence of brain retraction injury;

Countries

China

Contacts

Public ContactChen Liang

Huashan Hospital,Fudan University

chenlianghs@126.com+86 21 54601999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026